Indian pharma volume growth hits two-year peak at 3.4%

India's pharmaceutical market demonstrated robust momentum with volume growth accelerating to 3.4 per cent, marking the highest expansion in two years. The uptick reflects broad-based demand recovery across multiple therapy categories, signalling renewed health consciousness and improved access to medicines among Indian consumers.

Accompanying the volume surge, pricing dynamics remained favourable, with average price increases reaching approximately 6.2 per cent. The combination of volume and price growth underscores the sector's resilience and the market's capacity to absorb price adjustments amid steady consumption patterns.

The expansion was underpinned by consistent performance across therapy segments rather than concentrated gains in select categories. This diversified growth trajectory suggests the recovery is anchored in fundamental demand drivers rather than temporary or seasonal factors.

The figures point to a stabilising domestic pharmaceutical market following earlier slowdowns, with industry participants noting that improved economic conditions and healthcare awareness have contributed to the uptick. The two-year performance benchmark indicates the sector has moved past previous headwinds that had constrained growth.